
A research university with a pioneering technology transfer foundation and deep strength in biosciences.
Wisconsin created one of the earliest university technology transfer organisations in the world, the Wisconsin Alumni Research Foundation, which has funded university research from licensing income for roughly a century.
That structure shaped the university's approach to commercialisation long before most institutions had one, and it remains unusual in its independence and scale.
Madison's ecosystem is concentrated in biotechnology, medical devices, health software, and agricultural science, drawing directly on university research.
The city is small and the community correspondingly tight, which makes introductions straightforward but limits the pool of experienced operators.
Companies formed around the university concentrate in biotechnology, stem cell and regenerative medicine, diagnostics, and health information technology.
Its stem cell research history in particular seeded a cluster of regenerative medicine companies in the region.
Wisconsin has state-supported venture programmes, regional life science funds, and angel networks organised around the university.
Larger rounds typically involve investors from Chicago, Minneapolis, or the coasts.
GCN’s global network includes millions of startups and founders and a broad community of investors, creating opportunities to discover potential connections across university communities.
.png)




